Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K932787Substantially Equivalent

Batroxobin Reagent

Behring Diagnostics, Inc., Somerville NJ / Traditional, Substantially Equivalent

K932787 is the FDA 510(k) clearance record for BATROXOBIN REAGENT, a class II device, cleared for Behring Diagnostics, Inc. on under FDA product code JCO (Bothrops Atrox Reagent). FDA records list 145 510(k) clearances for Behring Diagnostics, Inc., from to . As of , FDA records show no recalls naming K932787.

Clearance record

Decision date
Received
(173 days to decision)
Product code
JCO Bothrops Atrox Reagent
Regulation
21 CFR 864.8100
Device class
Class II
Review panel
Hematology
Applicant
Behring Diagnostics, Inc. 17 Chubb Way, Somerville NJ
510(k) summary
Summary
Third party review
No

Clearances, product code JCO

Trailing 12 months

FDA records hold no clearances under product code JCO in the trailing twelve months.

FDA records show no clearances under product code JCO in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JCO, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260